Public Statements

Limit results to:

Date Range

Keyword Search

Search string must be longer than 3 characters.

results per page:
Date Title Politician
April 3, 2008 Letter to Kevin Sharer, Chairman, and CEO and President of Amgen Inc., Re: Increased Rebates to Physicians Prescribing Anti-Anemia Drugs Sen. Chuck Grassley
April 3, 2008 New Direction for Energy Independence, National Security, and Consumer Protection Act and the Renewable Energy and Energy Conservation Tax Act of 2007 Sen. Chuck Grassley
April 2, 2008 Letter to David Kotz, Inspector General of the US Securities and Exchange Commission - Review of SEC Decision to Decline Case Against Bear Stearns Sen. Chuck Grassley
April 2, 2008 New Direction for Energy Independence, National Security, and Consumer Protection Act and the Renewable Energy and Energy Conservation Tax Act of 2007 -- Motion to Proceed Sen. Chuck Grassley
March 31, 2008 Letter to Robert Byrd and Thad Cochran, Chairman and Ranking Member of the Senate Committee on Appropriations, Re: Restore Byrne/JAG Grants for State and Local Law Enforcement in Supplemental Appropriations Bill Sen. Chuck Grassley, ...
March 25, 2008 The Ottumwa Courier - "Miller-Meeks Kicks Off Campaign" Rep. Mariannette Miller-Meeks
March 13, 2008 Office of the Inspector General Report on National Security Letters Sen. Chuck Grassley
March 13, 2008 Letter to Andrew von Eschenbach, Commissioner of the U.S. Food and Drug Administration, Re: Changes to Improve FDA Post-Market Review Remain Elusive Sen. Chuck Grassley
March 13, 2008 Grassley Comments on FDA Advisory Committee Recommendations for Anti-Anemia Drugs Sen. Chuck Grassley
March 11, 2008 Letter to Michael Leavitt, Secretary of Health and Human Services, and Andrew von Eschenbach, Commissioner of the FDA, Re: Registration Fees for Inspection of Foreign Manufacturers of Pharmaceutical Drugs Sen. Chuck Grassley
March 5, 2008 Senate Committee On the Judiciary FBI Oversight Hearing Sen. Chuck Grassley
March 4, 2008 Grassley Secures Independent Review of FDA Approvals Based on Narrow Health Benefits Sen. Chuck Grassley
Feb. 28, 2008 Letter to Andrew von Eschenbach, Commissioner of the FDA, Re: Information About Foreign Inspections, Drug Safety Sen. Chuck Grassley
Feb. 21, 2008 Finance Leaders Aim to Help Seniors Seeking Addional Coverage From Medicare Drug Benefit Plans Sen. Chuck Grassley, ...
Feb. 20, 2008 Grassley, Leahy, Specter Applaud Focus on Most Effective Tool Against Fraud of Taxpayer Dollars Sen. Chuck Grassley, ...
Feb. 14, 2008 Grassley Says Hold on Imported Blood Thinner Component Underscores Questions About FDA Foreign Inspections Sen. Chuck Grassley
Feb. 14, 2008 Letter to Condoleezza Rice, Secretary of State, Re: Victims of Terror Seeking Justice Sen. Chuck Grassley, ...
Feb. 12, 2008 Letter to Fred Hassan, Chairman of the Board, Chief Executive Officer of the Schering-Plough Corporation, Re: Questions About Statements Regarding Drug Trial Sen. Chuck Grassley
Feb. 6, 2008 Letter to Christopher Viehbacher, President of GlaxoSmithKline, Re: Request for Key Documents Relating to Paxil Sen. Chuck Grassley
Jan. 30, 2008 Prepared Statement of Senator Chuck Grassley at the Justice Department Oversight Hearing Sen. Chuck Grassley
Jan. 30, 2008 Drug Safety Sen. Chuck Grassley
Jan. 30, 2008 Afternoon Session of a Hearing of the Senate Judiciary Committee - Oversight of the U.S. Department of Justice Sen. Chuck Grassley
Jan. 28, 2008 Grassley Comments on State of the Union Address Sen. Chuck Grassley
Jan. 11, 2008 Baucus, Grassley Comment on Report on Medicare Drug Benefit Payments to Community Pharmacies Sen. Chuck Grassley, ...
Jan. 10, 2008 Letter to Robert Mueller, Director of the FBI, Re: Mismanagement of Money Used in Undercover Investigations Sen. Chuck Grassley
Date Title Politician
April 3, 2008 Letter to Kevin Sharer, Chairman, and CEO and President of Amgen Inc., Re: Increased Rebates to Physicians Prescribing Anti-Anemia Drugs Sen.Chuck Grassley
April 3, 2008 New Direction for Energy Independence, National Security, and Consumer Protection Act and the Renewable Energy and Energy Conservation Tax Act of 2007 Sen.Chuck Grassley
April 2, 2008 Letter to David Kotz, Inspector General of the US Securities and Exchange Commission - Review of SEC Decision to Decline Case Against Bear Stearns Sen.Chuck Grassley
April 2, 2008 New Direction for Energy Independence, National Security, and Consumer Protection Act and the Renewable Energy and Energy Conservation Tax Act of 2007 -- Motion to Proceed Sen.Chuck Grassley
March 31, 2008 Letter to Robert Byrd and Thad Cochran, Chairman and Ranking Member of the Senate Committee on Appropriations, Re: Restore Byrne/JAG Grants for State and Local Law Enforcement in Supplemental Appropriations Bill Sen.Chuck Grassley, ...
March 25, 2008 The Ottumwa Courier - "Miller-Meeks Kicks Off Campaign" Rep.Mariannette Miller-Meeks
March 13, 2008 Office of the Inspector General Report on National Security Letters Sen.Chuck Grassley
March 13, 2008 Letter to Andrew von Eschenbach, Commissioner of the U.S. Food and Drug Administration, Re: Changes to Improve FDA Post-Market Review Remain Elusive Sen.Chuck Grassley
March 13, 2008 Grassley Comments on FDA Advisory Committee Recommendations for Anti-Anemia Drugs Sen.Chuck Grassley
March 11, 2008 Letter to Michael Leavitt, Secretary of Health and Human Services, and Andrew von Eschenbach, Commissioner of the FDA, Re: Registration Fees for Inspection of Foreign Manufacturers of Pharmaceutical Drugs Sen.Chuck Grassley
March 5, 2008 Senate Committee On the Judiciary FBI Oversight Hearing Sen.Chuck Grassley
March 4, 2008 Grassley Secures Independent Review of FDA Approvals Based on Narrow Health Benefits Sen.Chuck Grassley
Feb. 28, 2008 Letter to Andrew von Eschenbach, Commissioner of the FDA, Re: Information About Foreign Inspections, Drug Safety Sen.Chuck Grassley
Feb. 21, 2008 Finance Leaders Aim to Help Seniors Seeking Addional Coverage From Medicare Drug Benefit Plans Sen.Chuck Grassley, ...
Feb. 20, 2008 Grassley, Leahy, Specter Applaud Focus on Most Effective Tool Against Fraud of Taxpayer Dollars Sen.Chuck Grassley, ...
Feb. 14, 2008 Grassley Says Hold on Imported Blood Thinner Component Underscores Questions About FDA Foreign Inspections Sen.Chuck Grassley
Feb. 14, 2008 Letter to Condoleezza Rice, Secretary of State, Re: Victims of Terror Seeking Justice Sen.Chuck Grassley, ...
Feb. 12, 2008 Letter to Fred Hassan, Chairman of the Board, Chief Executive Officer of the Schering-Plough Corporation, Re: Questions About Statements Regarding Drug Trial Sen.Chuck Grassley
Feb. 6, 2008 Letter to Christopher Viehbacher, President of GlaxoSmithKline, Re: Request for Key Documents Relating to Paxil Sen.Chuck Grassley
Jan. 30, 2008 Prepared Statement of Senator Chuck Grassley at the Justice Department Oversight Hearing Sen.Chuck Grassley
Jan. 30, 2008 Drug Safety Sen.Chuck Grassley
Jan. 30, 2008 Afternoon Session of a Hearing of the Senate Judiciary Committee - Oversight of the U.S. Department of Justice Sen.Chuck Grassley
Jan. 28, 2008 Grassley Comments on State of the Union Address Sen.Chuck Grassley
Jan. 11, 2008 Baucus, Grassley Comment on Report on Medicare Drug Benefit Payments to Community Pharmacies Sen.Chuck Grassley, ...
Jan. 10, 2008 Letter to Robert Mueller, Director of the FBI, Re: Mismanagement of Money Used in Undercover Investigations Sen.Chuck Grassley
arrow_upward